Emma Richardson
Industry Practicum Projects
SwineSight
NanoString-Powered PRDC Surveillance
Fall 2025 CMI-BAM Project
This mini-project examined the market potential of a NanoString-based gene expression assay developed by Dr. Elisa Crisci’s team to improve the detection of Porcine Respiratory Disease Complex (PRDC). PRDC remains a leading cause of respiratory illness and economic loss in swine production, yet current diagnostic tools like RT-PCR and NGS are often limited by cost and turnaround time. The NanoString platform offers a high-throughput, low–hands-on alternative capable of simultaneously identifying multiple PRDC-associated pathogens. Our team evaluated how this assay fits within the current diagnostic landscape by benchmarking performance, assessing key competitors, and identifying strategic opportunities for differentiation and adoption across the swine health industry.
Building Bridges in Biotech
Technology Landscape and Partner Mapping
Fall 2025 Industry Practicum Project
This project supports Dr. Windsor, Associate Director of Scientific Engagement at FUJIFILM Biotechnologies, in advancing the company’s commitment to innovation and leadership in biologics manufacturing. As FUJIFILM looks to remain at the forefront of the industry, identifying academic collaborators working in emerging areas is essential—particularly in in silico cell simulation (digital twins) and cell-free protein synthesis (CFPS). Our team developed a strategic landscape assessment to guide future collaborations, including a foundational scientific review, an analysis of recent literature and technology trends, and a detailed mapping of academic researchers leading work in these fields. Together, these insights will help Dr. Windsor and FUJIFILM establish meaningful connections with innovators shaping the future of biomanufacturing.
Hognosis
Diagnostic Innovation in Animal Health
This project focused on bridging the gap between genomic research and commercial application within the $2B North Carolina swine industry. My work centered on defining the "diagnostic gap"—a $250M annual loss due to infectious disease—and articulating the value proposition for Hognosis, a diagnostic service utilizing NanoString technology. By shifting producers from reactive PCR testing to proactive, population-level surveillance of up to 800 pathogens, the solution provides a cost-effective strategy to reduce mortality and stabilize the regional food supply.
